Old Web
English
Sign In
Acemap
>
authorDetail
>
Christian Thoma
Christian Thoma
Boehringer Ingelheim
Medicine
Generalized pustular psoriasis
Immunology
Clinical endpoint
Placebo
4
Papers
114
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study.
2021
Dermatologic Therapy
Ulrich Mrowietz
A. David Burden
Andreas Pinter
Kristian Reich
Knut Schäkel
Patrick Baum
Yakov Datsenko
Hongjie Deng
Steven J. Padula
Christian Thoma
Robert Bissonnette
Show All
Source
Cite
Save
Citations (13)
Pustular psoriasis: molecular pathways and effects of spesolimab in generalized pustular psoriasis.
2021
The Journal of Allergy and Clinical Immunology
Patrick Baum
Sudha Visvanathan
Sandra Garcet
Janine Roy
Ramona Schmid
Sebastian Bossert
Benjamin Lang
Hervé Bachelez
Robert Bissonnette
Christian Thoma
James G. Krueger
Show All
Source
Cite
Save
Citations (0)
Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare.
2021
BMJ Open
Siew Eng Choon
Mark Lebwohl
Slaheddine Marrakchi
A. David Burden
Tsen-Fang Tsai
Akimichi Morita
Alexander A. Navarini
Min Zheng
Jinhua Xu
Hamida Turki
Sushmita Rajeswari
Hongjie Deng
Kay Tetzlaff
Christian Thoma
Hervé Bachelez
Show All
Source
Cite
Save
Citations (7)
Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis
2019
The New England Journal of Medicine
Hervé Bachelez
Siew Eng Choon
Slaheddine Marrakchi
A. David Burden
Tsen-Fang Tsai
Akimichi Morita
H. Turki
David Hall
Michael Shear
Patrick Baum
Steven John Padula
Christian Thoma
Show All
Source
Cite
Save
Citations (94)
1